Sermorelin
Worth trying, BioHarmony verdict
BioHarmony score 5.9 out of 10
Sermorelin (GHRH 1-29) is a short-acting peptide that prompts your own pituitary to release growth hormone, and it is the only one in its class with a former FDA approval and real human trials, per Thorner 1996. Adult anti-aging data is thin and mixed, with a null body-composition trial per Vittone 1997.
Read full reportWhat is Sermorelin?
Sermorelin is the synthetic 1-29 amino-acid fragment of growth-hormone-releasing hormone, the shortest piece of the natural signal that still tells your pituitary to fire off a pulse of growth hormone. Instead of injecting growth hormone directly, you nudge your own gland to release it the way it normally would, in a brief burst that rises and falls. That keeps your natural feedback brakes in place, which is the whole pitch for calling it more physiological than recombinant HGH.
From the BioHarmony report, reviewed Sep 8, 2026.
Saved on this device only.
How it is thought to work
Agonist at the pituitary GHRH receptor, amplifying the body's own pulsatile growth-hormone release
Safety watch-outs
- Progressive or worsening reaction with each injection (possible sensitization): stop immediately.
- New or worsening numbness or tingling (possible fluid-related nerve compression): reduce dose or stop.
- Rising fasting glucose: stop and consult a clinician, especially with diabetes or insulin resistance.
- Any active or suspected cancer: do not use
- growth-hormone-axis stimulation is contraindicated.
Full risk profile in the BioHarmony report.
Dosing as published
Source-reported figures only. This page does not calculate a personal dose.
Working with a vial? The reconstitution calculator covers mixing math, not dosing advice.
More reported protocols
MembersMembers can compare additional reported doses, schedules, and preparation notes.
Educator coverage (1)
Attributed viewpoints, separate from primary research.
- Sermorelin and Ipamorelin Blend: Benefits and Efficacy Jay Campbell,
Trust & sourcing
- Last revieweddone
- Next reviewupcoming
FDA records show that sermorelin acetate for injection was approved as Geref. The branded product is no longer marketed; compounded sermorelin products do not inherit the former product's approval.
Primary sources
- Geref (sermorelin acetate) approval package U.S. Food and Drug Administration,
Related peptides for recovery & tissue repair
- 7.4Thymosin Alpha-1Thymosin Alpha-1 is a 28-amino-acid thymic peptide with strongest evidence in immune-compromised and hospital-adjacent settings: Cao 2024 pooled 39 acute COPD…
- 7.2GHK-Cu (Copper Peptide)GHK-Cu is a human copper-binding tripeptide with the best evidence for topical skin repair and wound healing, including Mulder 1994 diabetic ulcer data showing 98.5%…
- 7.1SemaxSemax is a Russian-developed ACTH 4-7 + PGP heptapeptide with the strongest human signal in post-stroke recovery, including a 110-patient Gusev et al.
- 6.9Thymosin Beta-4 (Full)Thymosin beta-4 is the native 43-amino-acid peptide that promotes tissue repair via actin-sequestering and the Ac-SDKP repair axis.
The Ultimate Peptides Guide
Spot stronger candidates, weak evidence, and seller red flags before you buy.